Copper Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 2 pharmaceutical companies such as CURIUM, SEBELA WOMENS HLTH. It is marketed under 2 brand names, including DETECTNET, MIUDELLA. Available in 2 different strengths, such as 4mL (1mCi/ML), N/A, and administered through 2 routes including SOLUTION;INTRAVENOUS, SYSTEM;INTRAUTERINE.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 2 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"164457","ingredient":"COPPER","trade_name":"MIUDELLA","family_id":"","publication_number":"US10188546B2","cleaned_patent_number":"10188546","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-08-14","publication_date":"2019-01-29","legal_status":"Granted"} US10188546B2 Formulation 29 Jan, 2019 Granted 14 Aug, 2032
{"application_id":"164459","ingredient":"COPPER","trade_name":"MIUDELLA","family_id":"","publication_number":"US10159596B2","cleaned_patent_number":"10159596","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-08-14","publication_date":"2018-12-25","legal_status":"Granted"} US10159596B2 Formulation 25 Dec, 2018 Granted 14 Aug, 2032
{"application_id":"164455","ingredient":"COPPER","trade_name":"MIUDELLA","family_id":"","publication_number":"US11850181B2","cleaned_patent_number":"11850181","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-08-14","publication_date":"2023-12-26","legal_status":"Granted"} US11850181B2 Formulation 26 Dec, 2023 Granted 14 Aug, 2032
{"application_id":"164454","ingredient":"COPPER","trade_name":"MIUDELLA","family_id":"","publication_number":"US9427351B2","cleaned_patent_number":"9427351","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-08-14","publication_date":"2016-08-30","legal_status":"Granted"} US9427351B2 Formulation 30 Aug, 2016 Granted 14 Aug, 2032
{"application_id":"73495","ingredient":"COPPER CU-64 DOTATATE","trade_name":"DETECTNET","family_id":"35a3fc6c747848da9217","publication_number":"US11160888B2","cleaned_patent_number":"11160888","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-08-23","publication_date":"2021-11-02","legal_status":"Granted"} US11160888B2 02 Nov, 2021 Granted 23 Aug, 2032
{"application_id":"73483","ingredient":"COPPER CU-64 DOTATATE","trade_name":"DETECTNET","family_id":"35a3fc6c747848da9217","publication_number":"US10159759B2","cleaned_patent_number":"10159759","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-08-23","publication_date":"2018-12-25","legal_status":"Granted"} US10159759B2 25 Dec, 2018 Granted 23 Aug, 2032
{"application_id":"164462","ingredient":"COPPER","trade_name":"MIUDELLA","family_id":"","publication_number":"US9089418B2","cleaned_patent_number":"9089418","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-04-09","publication_date":"2015-07-28","legal_status":"Granted"} US9089418B2 Formulation 28 Jul, 2015 Granted 09 Apr, 2033
{"application_id":"73494","ingredient":"COPPER CU-64 DOTATATE","trade_name":"DETECTNET","family_id":"35a3fc6c747848da9217","publication_number":"US10383961B2","cleaned_patent_number":"10383961","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-07-02","publication_date":"2019-08-20","legal_status":"Granted"} US10383961B2 20 Aug, 2019 Granted 02 Jul, 2033
{"application_id":"164463","ingredient":"COPPER","trade_name":"MIUDELLA","family_id":"","publication_number":"US12138199B2","cleaned_patent_number":"12138199","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-10-18","publication_date":"2024-11-12","legal_status":"Granted"} US12138199B2 Formulation 12 Nov, 2024 Granted 18 Oct, 2033
{"application_id":"164452","ingredient":"COPPER","trade_name":"MIUDELLA","family_id":"","publication_number":"US9610191B2","cleaned_patent_number":"9610191","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-02-24","publication_date":"2017-04-04","legal_status":"Granted"} US9610191B2 04 Apr, 2017 Granted 24 Feb, 2034
{"application_id":"164451","ingredient":"COPPER","trade_name":"MIUDELLA","family_id":"","publication_number":"US10398588B2","cleaned_patent_number":"10398588","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-02-24","publication_date":"2019-09-03","legal_status":"Patented Case"} US10398588B2 Formulation 03 Sep, 2019 Patented Case 24 Feb, 2034
{"application_id":"164460","ingredient":"COPPER","trade_name":"MIUDELLA","family_id":"","publication_number":"US10022264B2","cleaned_patent_number":"10022264","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-03-22","publication_date":"2018-07-17","legal_status":"Granted"} US10022264B2 Formulation 17 Jul, 2018 Granted 22 Mar, 2034
{"application_id":"164453","ingredient":"COPPER","trade_name":"MIUDELLA","family_id":"","publication_number":"US9265652B2","cleaned_patent_number":"9265652","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-04-28","publication_date":"2016-02-23","legal_status":"Granted"} US9265652B2 23 Feb, 2016 Granted 28 Apr, 2034
{"application_id":"164461","ingredient":"COPPER","trade_name":"MIUDELLA","family_id":"","publication_number":"US10166141B2","cleaned_patent_number":"10166141","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-06-13","publication_date":"2019-01-01","legal_status":"Granted"} US10166141B2 Formulation 01 Jan, 2019 Granted 13 Jun, 2034
{"application_id":"164458","ingredient":"COPPER","trade_name":"MIUDELLA","family_id":"","publication_number":"US11207209B2","cleaned_patent_number":"11207209","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-08-16","publication_date":"2021-12-28","legal_status":"Granted"} US11207209B2 Formulation 28 Dec, 2021 Granted 16 Aug, 2034
{"application_id":"164456","ingredient":"COPPER","trade_name":"MIUDELLA","family_id":"","publication_number":"US10918516B2","cleaned_patent_number":"10918516","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-01-23","publication_date":"2021-02-16","legal_status":"Granted"} US10918516B2 Formulation 16 Feb, 2021 Granted 23 Jan, 2037
{"application_id":"138486","ingredient":"COPPER CU-64 DOTATATE","trade_name":"DETECTNET","family_id":"","publication_number":"US12102696B2","cleaned_patent_number":"12102696","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2041-09-03","publication_date":"2024-10-01","legal_status":"Granted"} US12102696B2 Formulation 01 Oct, 2024 Granted 03 Sep, 2041

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Copper

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.